This is because inositol improves insulin resistance (IR) by promoting the translocation of glucose transporter (GLUT4), enhancing cellular glucose uptake, thereby lowering fasting insulin levels (74) and regulating the signaling of FSH and LH, improving the LH/FSH ratio, reducing androgen levels, and thus alleviating hyperandrogenemia (75). Here, SLC2A4 is linked to polycystic ovary syndrome.